v3.20.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2020
Cash flows from operating activities:          
Net income $ 456,983 $ 380,305 $ 877,125 $ 726,701  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     164,323 187,122  
Loss (gain) on unrealized foreign exchange and other     (18,570) 4,763  
Asset impairment charges     865 2,581  
Stock-based compensation expense     53,819 53,733  
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:          
Accounts receivable     (117,189) (201,896)  
Inventories     (112,206) (6,568)  
Other assets     (51,287) (5,372)  
Accounts payable     (1,783) 54,143  
Deferred system revenue     (61,595) (35,245)  
Deferred service revenue     (1,431) (3,117)  
Other liabilities     341,181 107,131  
Net cash provided by operating activities     1,073,252 883,976  
Cash flows from investing activities:          
Proceeds from sale of assets     1,855 0  
Business acquisitions, net of cash acquired     0 (78,530)  
Capital expenditures     (115,069) (67,440)  
Purchases of available-for-sale securities     (492,048) (408,482)  
Proceeds from sale of available-for-sale securities     110,812 35,736  
Proceeds from maturity of available-for-sale securities     259,327 357,450  
Purchases of trading securities     (35,371) (21,873)  
Proceeds from sale of trading securities     39,668 27,212  
Proceeds from other investments     614 1,086  
Net cash used in investing activities     (230,212) (154,841)  
Cash flows from financing activities:          
Payment of debt issuance costs     40,343 0  
Proceeds from revolving credit facility     0 250,000  
Repayment of debt     (50,000) (275,000)  
Common stock repurchases     (365,389) (513,089)  
Payment of dividends to stockholders     (280,748) (256,332)  
Issuance of common stock     26,356 24,613  
Tax withholding payments related to vested and released restricted stock units     (36,145) (35,775)  
Payment of contingent consideration payable     0 (60)  
Net cash used in financing activities     (665,583) (805,643)  
Effect of exchange rate changes on cash and cash equivalents     19,600 378  
Net increase (decrease) in cash and cash equivalents     197,057 (76,130)  
Cash and cash equivalents at beginning of period     1,234,409 1,015,994 $ 1,015,994
Cash and cash equivalents at end of period $ 1,431,466 $ 939,864 1,431,466 939,864 $ 1,234,409
Supplemental cash flow disclosures:          
Income taxes paid     113,949 70,746  
Interest paid     76,996 79,486  
Non-cash activities:          
Contingent consideration (receivable) payable - financing activities     (8,748) 5,825  
Dividends payable - financing activities     1,203 3,190  
Unsettled common stock repurchase - financing activities     6,000 4,000  
Accrued purchases of land, property and equipment - investing activities     $ 25,987 $ 13,755  

Source